Additive Effects of Angiotensin Receptor-Neprilysin Inhibitors and Sodium-Glucose Cotransporter 2 Inhibitors on Neurohormonal Inhibition Therapy in Severe HFrEF: A Systematic Review and Network Meta-analysis.

Saved in:
Bibliographic Details
Title: Additive Effects of Angiotensin Receptor-Neprilysin Inhibitors and Sodium-Glucose Cotransporter 2 Inhibitors on Neurohormonal Inhibition Therapy in Severe HFrEF: A Systematic Review and Network Meta-analysis.
Authors: Suzuki K; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan. kojisuzu@hama-med.ac.jp., Osa S; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan., Takeshita S; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan., Noda M; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan., Yagi T; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan., Maekawa Y; Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan., Kawakami J; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Source: American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2026 May; Vol. 26 (3), pp. 323-333. Date of Electronic Publication: 2026 Jan 18.
Publication Type: Journal Article; Systematic Review; Network Meta-Analysis
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100967755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-187X (Electronic) Linking ISSN: 11753277 NLM ISO Abbreviation: Am J Cardiovasc Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first